34 results
Page 2 of 2
6-K
EX-99.2
zltsq4 yoj8
31 Aug 21
Index to the Unaudited Interim Condensed Consolidated Financial Statements
4:16pm
6-K
EX-99.1
rapfl
31 Aug 21
Index to the Unaudited Interim Condensed Consolidated Financial Statements
4:16pm
6-K
EX-99.2
d81dm07bnprdvcxaw5nc
3 Jun 21
Development program exploring the potential of CBP-174 in the treatment of chronic inflammatory pruritus
6:04am
424B4
b739q8ga3nrfx6ik9
19 Mar 21
Prospectus supplement with pricing info
4:49pm
F-1/A
mg9phh iqlja9
18 Mar 21
Registration statement (foreign) (amended)
6:15am
F-1/A
x6y1vhewakwak
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
F-1/A
EX-99.1
3r1bloqs5w xi
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
CORRESP
naqutxcr53oi3e 3rf
8 Mar 21
Correspondence with SEC
12:00am
F-1
EX-10.10
t35ptz48dqe5x
26 Feb 21
Registration statement (foreign)
4:56pm
F-1
6gwkqrn
26 Feb 21
Registration statement (foreign)
4:56pm
F-1
EX-10.15
1cjp9ki7l
26 Feb 21
Registration statement (foreign)
4:56pm
DRS/A
lm68yno 5w4
26 Jan 21
Draft registration statement (amended)
12:00am
DRS
5nfuu8vl9
17 Dec 20
Draft registration statement
12:00am
DRS
EX-10.7
a25 ts47xvwxv
17 Dec 20
Draft registration statement
12:00am